Long-term metabolic risk for the metabolically healthy overweight/obese phenotype

[1] Jensen MD(2014)2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society Circulation 129 S102-S138

[2] Ryan DH(2014)Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population Eur J Nutr 53 1345-1353

[3] Apovian CM(2013)Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study Diabetes Care 36 2388-2394

[4] Ard JD(2015)Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study Eur Heart J 36 551-559

[5] Comuzzi AG(2013)Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese youth Pediatrics 132 e85-e92

[6] Donato KA(2010)Metabolically healthy obesity: different prevalences using different criteria Eur J Clin Nutr 64 1043-1051

[7] Schroder H(2013)Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis Ann Intern Med 159 758-769

[8] Ramos R(2014)Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway J Am Coll Cardiol 63 1071-1078

[9] Baena-Diez JM(2012)Incident cardiovascular disease events in metabolically benign obese individuals Obesity 20 651-659

[10] Mendez MA(2016)The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis J Epidemiol Community Health 70 1024-1031

[1] Jensen MD(2014)2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society Circulation 129 S102-S138

[2] Ryan DH(2014)Determinants of the transition from a cardiometabolic normal to abnormal overweight/obese phenotype in a Spanish population Eur J Nutr 53 1345-1353

[3] Apovian CM(2013)Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study Diabetes Care 36 2388-2394

[4] Ard JD(2015)Metabolically healthy obesity and the risk of cardiovascular disease and type 2 diabetes: the Whitehall II cohort study Eur Heart J 36 551-559

[5] Comuzzi AG(2013)Cardiorespiratory fitness and adiposity in metabolically healthy overweight and obese youth Pediatrics 132 e85-e92

[6] Donato KA(2010)Metabolically healthy obesity: different prevalences using different criteria Eur J Clin Nutr 64 1043-1051

[7] Schroder H(2013)Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis Ann Intern Med 159 758-769

[8] Ramos R(2014)Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals: HUNT (Nord-Trondelag Health Study), Norway J Am Coll Cardiol 63 1071-1078

[9] Baena-Diez JM(2012)Incident cardiovascular disease events in metabolically benign obese individuals Obesity 20 651-659

[10] Mendez MA(2016)The long-term prognosis of cardiovascular disease and all-cause mortality for metabolically healthy obesity: a systematic review and meta-analysis J Epidemiol Community Health 70 1024-1031